Brief: Absci Corp Expects To Initiate Investigational New Drug Application Enabling Studies For Abs-101 In Feb 2024

Jan 8 (Reuters) - Absci Corp  ABSI.O :
    * ABSCI CORP: EXPECTS TO INITIATE INVESTIGATIONAL NEW DRUG
APPLICATION (IND) ENABLING STUDIES FOR ABS-101 IN FEB 2024, AND
SUBMIT AN IND IN Q1 2025

Source text for Eikon:  ID:nGNX2Dtq2s 
Further company coverage:  ABSI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on AbSci

See all news